KATHERINE KOSHOFER: Open Payments
NPI 1720209935 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 40 payments from 7 companies in 2025. Trend: 2023 $700 · 2024 $623 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $210 |
| Abbott Laboratories | 4 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| Amgen Inc. | 5 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Exact Sciences Corporation | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: FREESTYLE LIBRE 3, XIFAXAN, Ozempic, AIRSUPRA, EVENITY, Rybelsus, REPATHA, The Cologuard Plus Collection Kit.
Industry payments across AL — which companies pay providers there.
